Public Device Companies Take a Hit, But Still Stand

By Tom Salemi, IN VIVO 11/1/2008

• Feature Articles
• Word Count: 2043
• Art # 2008800172

Executive Summary

IN VIVO -- The health care sector has traditionally provided a haven for investors seeking the security of an industry blessed with a rock solid customer base. After all, consumer confidence plays a limited role in the bulk of health care decisions. But IN VIVO's survey of 62 publicly traded medical device companies shows the sector has taken a beating along with the rest of Wall Street. Surprisingly, potentially vulnerable sectors, like orthopedics and big ticket equipment, have shown a remarkable resiliency.

For $125, purchase this 2043-word article as a PDF, and receive immediate delivery via email. View a complete sample article.
Questions? Call Toll Free (800) 332-2181 or (908) 547-2159.

100% Satisfaction Guarantee